HK Stock MarketDetailed Quotes

03320 CHINARES PHARMA

Watchlist
  • 5.430
  • +0.020+0.37%
Not Open Dec 16 16:08 CST
34.11BMarket Cap8.24P/E (TTM)

About CHINARES PHARMA Company

China Resources Pharmaceutical Group Co., Ltd. (stock code: 3320) is a leading comprehensive pharmaceutical company in China. Its business scope covers the production, distribution and retail of pharmaceuticals and health products. The Group was founded in 2007 and has now developed into one of the top five pharmaceutical manufacturers in China and the top three distributors of pharmaceutical products in China (by revenue). The Company successfully completed its global sale in Hong Kong in October 2016. Our manufacturing business covers R&D, production and sales of pharmaceuticals and health care products. We produce 792 kinds of drugs, of which 430 products have entered the national medical insurance catalogue. The product portfolio includes chemicals, traditional Chinese medicine, biopharmaceuticals and nutritional health products, covering a wide range of therapeutic areas, including cardiovascular, digestive tract and metabolism, high-volume intravenous injections, pediatrics, respiratory system, skin, etc. Furthermore, we have many well-known brands such as “999,” “Donga Ejiao,” “Shuanghe,” “Zizhu,” “Jiangzhong,” “Boya,” and “Kunming Traditional Chinese Medicine,” and our business covers categories such as colds, gastrointestinal, skin, pediatrics, orthopedics, and blood products. In the future, we will actively expand to health management and chronic disease management products to meet the full cycle and multi-level health needs of Chinese families from prevention, care, treatment, and rehabilitation. We regard R&D innovation as an important driving force for long-term development, and continue to increase investment in R&D. We have a national key laboratory, five national engineering technology research centers, a national industrial innovation center, three national enterprise technology centers, more than 70 provincial and municipal R&D platforms, and postdoctoral research workstations. With our comprehensive product supply and extensive distribution network, we distribute products directly to hospitals and other medical institutions in China. We operate a nationwide distribution network composed of more than 220 logistics centers, strategically covering 28 provinces, municipalities and autonomous regions in China. The number of customers exceeds 0.21 million, including more than 10,000 secondary and tertiary hospitals, and about 90,000 customers in primary care institutions. Additionally, we operate one of the largest retail pharmacy networks in China. We operate 760 retail pharmacies under high-quality national or regional brands such as “China Resources Tang” and “Dexin Bank”, including 275 pharmacies specializing in DTP (including 162 “dual channel” pharmacies).

Company Profile

Symbol03320
Company NameCHINARES PHARMA
ISINHK0000311099
Listing DateOct 28, 2016
Issue Price9.10
Shares Offered1.54B share(s)
FoundedMay 10, 2007
Registered AddressHong Kong, China
Chairmanxiaosong bai
Secretaryguiyu zheng
Audit InstitutionErnst & Young
Company CategoryOverseas registration of Mainland State-owned Assets control
Registered Office41 / F, China Resources Building, 26 Harbour Road, Wan Chai, Hong Kong, China
Head Office and Principal Place of BusinessRoom 4104-05, 41st Floor, China Resources Building, 26 Harbour Road, Wanchai, Hong Kong
Fiscal Year Ends12-31
Employees72764
MarketHong Kong motherboard
Phone852-25938991
Fax852-25938992
Emailpub@crpharm.com
Business China Resources Pharmaceuticals Group Limited is an investment holding company in Hong Kong, China. The company and its subsidiaries are mainly engaged in R&D, manufacturing, distribution and retail of pharmaceuticals and other health products. The company mainly operates through three divisions. The Pharmaceutical Division develops, manufactures and sells pharmaceuticals and nutraceutical products. The Pharmaceutical Distribution Division provides distribution solutions to pharmaceutical manufacturers and dispensers, such as hospitals and other medical institutions, distributors and retail pharmacies. The Pharmaceutical Retail Division operates retail pharmacies in mainland China and Hong Kong, China.

Company Executives

  • Name
  • Position
  • Salary
  • xiaosong bai
  • Chairman of the Board, Executive Director, Chairman of the Executive Committee, Chairman of the Nomination Committee, Authorized Representative
  • 3.60M
  • ran tao
  • VP, Executive Director, Executive Committee Members
  • 2.94M
  • rong deng
  • Executive Director, Chief Financial Officer, Executive Committee Members
  • 11.00K
  • wei guo
  • Non-executive Directors, Audit Committee Members
  • --
  • yongqiang sun
  • Non-executive Directors, Remuneration Committee Members
  • --
  • chuan guo
  • Non-executive Directors
  • --
  • ruifang jiao
  • Non-executive Directors, Audit Committee Members
  • --
  • muxian sheng
  • Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
  • 270.00K
  • jianxun guo
  • Independent Non-Executive Director, Remuneration Committee Chairman, Nomination Committee Members, Audit Committee Members
  • 270.00K
  • tingmei fu
  • Independent Non-Executive Director, Remuneration Committee Members, Nomination Committee Members, Audit Committee Members
  • 270.00K
  • kejian zhang
  • Independent Non-Executive Director, Audit Committee Members, Nomination Committee Members, Remuneration Committee Members
  • 270.00K
  • huawei qiu
  • China Resources 39 and Chairman of Kunming Pharmaceutical Group Co., Ltd.
  • --
  • wenchao lu
  • Chairman of China Resources Shuanghe
  • --
  • jianjun wu
  • General Commercial Manager of China Resources Pharmaceuticals
  • --
  • weiquan liu
  • Chairman of Jiangzhong Pharmaceutical
  • --
  • jie cheng
  • President of Ejiao
  • --
  • zhangan liu
  • VP
  • --
  • kai qiu
  • Discipline Inspection Commission Records
  • --
  • na tang
  • General Counsel
  • --
  • xingpin cui
  • VP
  • --
  • yipeng liu
  • Secretary of the Discipline Inspection Commission
  • --
  • qingsheng meng
  • VP
  • --
  • guiyu zheng
  • Authorized Representative, Company Secretary
  • --
Trending HK Stocks
HK Crypto ETF HK Crypto ETF

An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data. An exchange-traded fund designed to track the price performance of Bitcoin or other major crypto, allowing investors to participate in the market without directly purchasing the assets.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK Crypto ETF, ranked from highest to lowest based on real-time market data.